cp-18
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01362712)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- cp18
- cp18
- cp-18
- cp-18
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01766622 | Phase 2 | Nov 30, 2012 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT01362712 | Phase 1 | May 1, 2011 | Certus International, Siemens |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Certus International | For profit | 1 | 0 | 1 | 2011 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2012 |
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 2012 |
| Siemens | For profit | 1 | 1 | 1 | 2011 |
4 organizations
Page 1 / 1